By occupying GLP-1 receptors in the brain, the medication promotes insulin release, slows gastric emptying, reduces glucagon secretion from the liver, and affects the hunger control centre (lateral hypothalamus) of the brain to suppress appetite
In addition, many people have sensitivity to eggs that can be exacerbated on Ozempic
They also need to be taken on an empty stomach in the morning, which may require some adjustment to ones daily routine
Notably, only one registered clinical study exists to date, which evaluates an implant-based delivery system of Exenatide and is currently in Phase 1 with an Active, not recruiting status (NCT05670379), initiated on December 20, 2024, and expected to conclude by August 2025